I think we'll begin to see an acceleration of drug research. Pharmaceutical trials typically take over a decade to complete, so the drugs available for general use now were devised back in the 1990s. Back then, clinical trials were largely paper-based, and needed to have a relatively large number of subjects to be proven safe.
Nowadays clinical trials are usually managed by web applications, which give a real-time view of how the trial is progressing. We're also beginning to see drug trials targeted at specific generic groups. The idea is that you need a smaller sample size to prove a drug works for a certain genetic subset of the population, so less initial investment is required. If the drug is successful, further trials can expand the number of people that can use it.
Nowadays clinical trials are usually managed by web applications, which give a real-time view of how the trial is progressing. We're also beginning to see drug trials targeted at specific generic groups. The idea is that you need a smaller sample size to prove a drug works for a certain genetic subset of the population, so less initial investment is required. If the drug is successful, further trials can expand the number of people that can use it.